The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.14
Bid: 0.13
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.02 (15.385%)
Open: 0.14
High: 0.14
Low: 0.14
Prev. Close: 0.14
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Omega Oil & Gas Limited

25 Oct 2022 12:16

RNS Number : 0563E
Gunsynd PLC
25 October 2022
 

25 October 2022

Gunsynd plc

 

("Gunsynd" or the "Company")

 

Investment in Omega Oil & Gas Limited

 

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) announces that it has invested AUD$90,000 (approximately £50,000) into Omega Oil & Gas Limited ("Omega") (ASX: OMA), an ASX listed Australian energy and resources company focused on natural gas exploration and oil production.

 

Omega commenced trading on the ASX at 12:00PM AEDT on Tuesday, 25 October 2022. Omega raised $15,070,000, through the issue of 75,350,000 shares at an issue price of $0.20 per share (the "Fundraise").

Gunsynd subscribed for 450,000 shares at AUD 20 cents for a total consideration of AUD$90,000 (the "Investment") as part of the Fundraise, from the Company's existing cash resources.

 

Omega holds two explorations permits ("Authority to Prospect" or "ATP") (ATP 2037 and ATP 2038) and a petroleum licence ("PL"), PL 17, in the Surat-Bowen Basin in South-East Queensland, Australia. Omega was incorporated in September 2020 to acquire Cypress Petroleum Pty Ltd from Tag Oil, a TSX listed oil and gas company. Through its acquisition of Cypress Petroleum, Omega holds 100% of ATP 2037, ATP 2038 and PL 17, which together represent a diversified portfolio of exploration and production assets.

Omega intends to execute a two well drilling campaign across both ATP 2037 and ATP 2038, focusing on the Kianga Formation in the Permian. This drilling campaign has two goals; to validate basin centred play, specifically the feasibility of commingled multi-facies production in the Taroom Trough, and to prove commercial prospectivity of the Permian Deep Gas by the application of a fit-for-purpose low cost well design. If successful, these activities will ultimately prove the viability of future gas and liquids development. This drilling campaign, if successful, will materially de-risk the Taroom Trough as a future gas producer in the years to come.

Gunsynd holds 450,000 ordinary shares in Omega representing approximately 0.4% of Omega's issued share capital.

 

For the year ended 30 June 2022, Omega had turnover of AUD$27,706 and made a loss of AUD$2,005,513.

 

The Directors of Gunsynd accept responsibility for this announcement.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPGAGUUPPGGA
Date   Source Headline
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights
25th Apr 200710:45 amRNSDirector/PDMR Shareholding
24th Apr 20074:12 pmRNSAdditional Listing
20th Apr 20072:15 pmRNSDirector/PDMR Shareholding
19th Apr 20077:01 amRNSInterim Results
21st Mar 20075:43 pmRNSHolding(s) in Company
20th Mar 20075:26 pmRNSHolding(s) in Company
15th Mar 20075:01 pmRNSHolding(s) in Company
31st Jan 20077:01 amRNSPipeline Update
8th Jan 20075:57 pmRNSDirector/PDMR Shareholding
13th Dec 200610:08 amRNSTotal Voting Rights
13th Dec 20067:01 amRNSBoard Changes
21st Nov 20067:01 amRNSAnnual Report & Notice of AGM
28th Sep 20067:02 amRNSPreliminary Results
1st Aug 20067:01 amRNSProduct Development Update
26th Jun 20067:01 amRNSCOO & Board Appointment
3rd Apr 20064:23 pmRNSHolding(s) in Company
23rd Mar 20068:12 amRNSSyntopix Admission to AIM
23rd Mar 20068:11 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.